Caplan, LR. Evidence based medicine: Concerns of a clinical neurologist. J Neurol Neurosurg Psychiatry. 2001;71:569–574Google Scholar

Thibault, GE. Too old for what? N Engl J Med. 1993;328:946–950Google Scholar

Caplan, LR. Reperfusion of ischemic brain: Why and why not? In Hacke GDZ, W, Hirschberg, M, eds. Thrombolytic therapy in acute ischemic stroke. Berlin: Springer; 1991:36–45Google Scholar

Pan, J, Konstas, A-A, Bateman, B, Ortolano, G, Pile-Spellman, J. Reperfusion injury following cerebral ischemia: Pathophysiology, MR imaging, and potential therapies. Neuroradiology. 2007;49:93–102CrossRefGoogle ScholarPubMed

Albers, GW, Thijs, VN, Wechsler, L, Kemp, S, Schlaug, G, Skalabrin, E, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508–517Google Scholar

Caplan, LR. Are terms such as completed stroke or RIND of continued usefulness? Stroke. 1983;14:431–433Google Scholar

Caplan, LR. TIAs: We need to return to the question, “What is wrong with Mr Jones?” Neurology. 1988;38:791–793Google Scholar

Cebul, RD, Snow, RJ, Pine, R, Hertzer, NR, Norris, DG. Indications, outcomes, and provider volumes for carotid endarterectomy. JAMA. 1998;279:1282–1287CrossRefGoogle ScholarPubMed

Wennberg, DE, Lucas, FL, Birkmeyer, JD, Bredenberg, CE, Fisher, ES. Variation in carotid endarterectomy mortality in the medicare population: Trial hospitals, volume, and patient characteristics. JAMA. 1998;279:1278–1281Google Scholar

Robinson, RG, Spalletta, G. Poststroke depression: A review. Can J Psychiatry. 2010;55:341–349Google Scholar

Robinson, RG, Lipsey, JR, Price, TR. Diagnosis and clinical management of post-stroke depression. Psychosomatics. 1985;26:769–772, 775–768Google Scholar

Alberts, MJ, Hademenos, G, Latchaw, RE, Jagoda, A, Marler, JR, Mayberg, MR, et al. Recommendations for the establishment of primary stroke centers. Brain attack coalition. JAMA. 2000;283:3102–3109Google Scholar

Alberts, MJ, Latchaw, RE, Selman, WR, Shephard, T, Hadley, MN, Brass, LM, et al. Recommendations for comprehensive stroke centers: A consensus statement from the brain attack coalition. Stroke. 2005;36:1597–1616Google Scholar

Song, S, Saver, J. Growth of regional acute stroke systems of care in the United States in the first decade of the 21st century. Stroke. 2012;43:1975–1978Google Scholar

Indredavik, B, Slordahl, SA, Bakke, F, Rokseth, R, Haheim, LL. Stroke unit treatment. Long-term effects. Stroke. 1997;28:1861–1866Google Scholar

Diez-Tejedor, E, Fuentes, B. Acute care in stroke: Do stroke units make the difference? Cerebrovasc Dis. 2001;11 Suppl 1:31–39CrossRefGoogle ScholarPubMed

Birbeck, GL, Zingmond, DS, Cui, X, Vickrey, BG. Multispecialty stroke services in California hospitals are associated with reduced mortality. Neurology. 2006;66:1527–1532Google Scholar

Leys, D, Ringelstein, EB, Kaste, M, Hacke, W. The main components of stroke unit care: Results of a European expert survey. Cerebrovasc Dis. 2007;23:344–352CrossRefGoogle ScholarPubMed

Candelise, L, Gattinoni, M, Bersano, A, Micieli, G, Sterzi, R, Morabito, A. Stroke-unit care for acute stroke patients: An observational follow-up study. Lancet. 2007;369:299–305Google Scholar

Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013;9: CD000197Google Scholar

Indredavik, B, Bakke, F, Solberg, R, Rokseth, R, Haaheim, LL, Holme, I. Benefit of a stroke unit: A randomized controlled trial. Stroke. 1991;22:1026–1031CrossRefGoogle ScholarPubMed

Stroke Unit Trialists’ Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151–1159Google Scholar

Stroke Unit Trialists’ Collaboration. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke. 1997;28:2139–2144Google Scholar

Xian, Y, Holloway, RG, Chan, PS, Noyes, K, Shah, MN, Ting, HH, et al. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA. 2011;305:373–380Google Scholar

Caplan, LR, Sergay, S. Positional cerebral ischaemia. J Neurol Neurosurg Psychiatry. 1976;39:385–391Google Scholar

Toole, JF. Effects of change of head, limb and body position on cephalic circulation. N Engl J Med. 1968;279:307–311Google Scholar

Wojner-Alexander, AW, Garami, Z, Chernyshev, OY, Alexandrov, AV. Heads down: Flat positioning improves blood flow velocity in acute ischemic stroke. Neurology. 2005;64:1354–1357Google Scholar

Favilla, CG, Mesquita, RC, Mullen, M, Durduran, T, Lu, X, Kim, MN, et al. Optical bedside monitoring of cerebral blood flow in acute ischemic stroke patients during head-of-bed manipulation. Stroke. 2014;45:1269–1274Google Scholar

Rordorf, G, Cramer, SC, Efird, JT, Schwamm, LH, Buonanno, F, Koroshetz, WJ. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke. 1997;28:2133–2138Google Scholar

Hillis, AE, Ulatowski, JA, Barker, PB, Torbey, M, Ziai, W, Beauchamp, NJ, et al. A pilot randomized trial of induced blood pressure elevation: Effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis. 2003;16:236–246CrossRefGoogle ScholarPubMed

Chalela, JA, Dunn, B, Todd, JW, Warach, S. Induced hypertension improves cerebral blood flow in acute ischemic stroke. Neurology. 2005;64:1979Google Scholar

Hillis, AE, Kane, A, Tuffiash, E, Ulatowski, JA, Barker, PB, Beauchamp, NJ, et al. Reperfusion of specific brain regions by raising blood pressure restores selective language functions in subacute stroke. Brain Lang. 2001;79:495–510Google Scholar

Lehv, MS, Salzman, EW, Silen, W. Hypertension complicating carotid endarterectomy. Stroke. 1970;1:307–313Google Scholar

Holton, P, Wood, JB. The effects of bilateral removal of the carotid bodies and denervation of the carotid sinuses in two human subjects. J Physiol. 1965;181:365–378Google Scholar

Breen, JC, Caplan, LR, DeWitt, LD, Belkin, M, Mackey, WC, O’Donnell, TP. Brain edema after carotid surgery. Neurology. 1996;46:175–181Google Scholar

Caplan, LR, Skillman, J, Ojemann, R, Fields, WS. Intracerebral hemorrhage following carotid endarterectomy: A hypertensive complication? Stroke. 1978;9:457–460Google Scholar

Ogasawara, K, Sakai, N, Kuroiwa, T, Hosoda, K, Iihara, K, Toyoda, K, et al. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: Retrospective review of 4494 patients. Journal of Neurosurgery. 2007;107:1130–1136Google Scholar

North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453Google Scholar

European Carotid Surgery Trialists’ Collaborative Group. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet. 1991;337:1235–1243Google Scholar

Brott, TG, Halperin, JL, Abbara, S, Bacharach, JM, Barr, JD, Bush, RL, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the management of patients with extracranial carotid and vertebral artery disease: Executive summary. Circulation. 2011;124:489–532Google Scholar

Barnett, HJ, Taylor, DW, Eliasziw, M, Fox, AJ, Ferguson, GG, Haynes, RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial collaborators. N Engl J Med. 1998;339:1415–1425Google Scholar

European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379–1387Google Scholar

Spetzler, RF, Hadley, MN, Martin, NA, Hopkins, LN, Carter, LP, Budny, J. Vertebrobasilar insufficiency. Part 1: Microsurgical treatment of extracranial vertebrobasilar disease. J Neurosurg. 1987;66:648–661Google Scholar

Kieffer, E, Koskas, F, Bahnini, A, et al. Long-term results after reconstruction of the cervical vertebral artery. In Caplan, LR, Shifrin, EG, Nicolaides, AN, Moore, WS, eds. Cerebrovascular Ischaemia – Investigation and Management. London: Med-Orion; 1996: 617–625Google Scholar

Berguer, R, Flynn, LM, Kline, RA, Caplan, LR. Surgical reconstruction of the extracranial vertebral artery: Management and outcome. J Vasc Surg. 2000;31:9–18Google Scholar

Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421–1428Google Scholar

Halliday, A, Mansfield, A, Marro, J, Peto, C, Peto, R, Potter, J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet. 2004;363:1491–1502Google Scholar

Hopkins, LN, Martin, NA, Hadley, MN, Spetzler, RF, Budny, J, Carter, LP. Vertebrobasilar insufficiency. Part 2. Microsurgical treatment of intracranial vertebrobasilar disease. J Neurosurg. 1987;66:662–674Google Scholar

Ausman, JI, Diaz, FG, Pearce, JE, de los Reyes, RA, Leuchter, W, Mehta, B, et al. Endarterectomy of the vertebral artery from C2 to posterior inferior cerebellar artery intracranially. Surg Neurol. 1982;18:400–404Google Scholar

Meyer, FB, Piepgras, DG, Sundt, TM Jr., Yanagihara, T. Emergency embolectomy for acute occlusion of the middle cerebral artery. J Neurosurg. 1985;62:639–647Google Scholar

Kerber, C W, Cromwell, L D, Loehden, O L. Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. AJNR Am J Neuroradiol. 1980;1:348–349Google Scholar

Kachel, R. Results of balloon angioplasty in the carotid arteries. J Endovasc Surg 1996;3:22–30Google Scholar

Caplan, LR, Meyers, PM, Schumacher, HC. Angioplasty and stenting to treat occlusive vascular disease. Rev Neurol Dis. 2006;3:8–18Google Scholar

Wholey, MH, Wholey, M, Mathias, K, Roubin, GS, Diethrich, EB, Henry, M, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv. 2000;50:160–167Google Scholar

Roubin, GS, New, G, Iyer, SS, Vitek, JJ, Al-Mubarak, N, Liu, MW, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: A 5-year prospective analysis. Circulation. 2001;103:532–537Google Scholar

Crawley, F, Clifton, A, Buckenham, T, Loosemore, T, Taylor, RS, Brown, MM. Comparison of hemodynamic cerebral ischemia and microembolic signals detected during carotid endarterectomy and carotid angioplasty. Stroke. 1997;28:2460–2464Google Scholar

Eckert, B, Thie, A, Valdueza, J, Zanella, F, Zeumer, H. Transcranial Doppler sonographic monitoring during percutaneous transluminal angioplasty of the internal carotid artery. Neuroradiology. 1997;39:229–234Google Scholar

Markus, HS, Clifton, A, Buckenham, T, Brown, MM. Carotid angioplasty. Detection of embolic signals during and after the procedure. Stroke. 1994;25:2403–2406Google Scholar

McCleary, AJ, Nelson, M, Dearden, NM, Calvey, TA, Gough, MJ. Cerebral haemodynamics and embolization during carotid angioplasty in high-risk patients. Br J Surg. 1998;85:771–774Google Scholar

Ribo, M, Molina, CA, Alvarez, B, Rubiera, M, Alvarez-Sabin, J, Matas, M. Transcranial Doppler monitoring of transcervical carotid stenting with flow reversal protection: A novel carotid revascularization technique. Stroke. 2006;37:2846–2849Google Scholar

Hofmann, R, Niessner, A, Kypta, A, Steinwender, C, Kammler, J, Kerschner, K, et al. Risk score for peri-interventional complications of carotid artery stenting. Stroke. 2006;37:2557–2561Google Scholar

Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVITAS): A randomised trial. Lancet. 2001;357:1729–1737Google Scholar

Brown, MM. Vascular Surgical Society of Great Britain and Ireland: Results of the Carotid and Vertebral Artery Transluminal Angioplasty Study. Br J Surg. 1999;86:710–711Google Scholar

Coward, LJ, McCabe, DJ, Ederle, J, Featherstone, RL, Clifton, A, Brown, MM. Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVITAS): A randomized trial. Stroke. 2007;38:1526–1530Google Scholar

Ederle, J, Bonati, LH, Dobson, J, Featherstone, RL, Gaines, PA, Beard, JD, et al. Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVITAS): Long-term follow-up of a randomised trial. Lancet Neurol. 2009;8:898–907Google Scholar

Bonati, LH, Ederle, J, McCabe, DJ, Dobson, J, Featherstone, RL, Gaines, PA, et al. Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): Long-term follow-up of a randomised trial. Lancet Neurol. 2009;8:908–917Google Scholar

Yadav, JS, Wholey, MH, Kuntz, RE, Fayad, P, Katzen, BT, Mishkel, GJ, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–1501Google Scholar

Ringleb, PA, Allenberg, J, Bruckmann, H, Eckstein, HH, Fraedrich, G, Hartmann, M, et al. 30 day results from the space trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial. Lancet. 2006;368:1239–1247Google Scholar

Mas, JL, Chatellier, G, Beyssen, B, Branchereau, A, Moulin, T, Becquemin, JP, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355:1660–1671Google Scholar

Qureshi, AI. Carotid angioplasty and stent placement after EVA-3S trial. Stroke. 2007;38:1993–1996Google Scholar

Brott, TG, Hobson, RW 2nd, Howard, G, Roubin, GS, Clark, WM, Brooks, W, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11–23Google Scholar

Voeks, JH, Howard, G, Roubin, GS, Malas, MB, Cohen, DJ, Sternbergh, WC 3rd, et al. Age and outcomes after carotid stenting and endarterectomy: The Carotid Revascularization Endarterectomy Versus Stenting Trial. Stroke. 2011;42:3484–3490Google Scholar

Choi, JC, Johnston, C, Kim, AS. Early outcomes after carotid artery stenting compared with endarterectomy for asymptomatic carotid stenosis. Stroke 2015;46:120–125CrossRefGoogle ScholarPubMed

Hadjipetrou, P, Cox, S, Piemonte, T, Eisenhauer, A. Percutaneous revascularization of atherosclerotic obstruction of aortic arch vessels. J Am Coll Cardiol. 1999;33:1238–1245CrossRefGoogle ScholarPubMed

Motarjeme, A. Percutaneous transluminal angioplasty of supra-aortic vessels. J Endovasc Surg. 1996;3:171–181Google Scholar

Wada, T, Takayama, K, Taoka, T, Nakagawa, H, Myouchin, K, Miyasaka, T, et al. Long-term treatment outcomes after intravascular ultrasound evaluation and stent placement for atherosclerotic subclavian artery obstructive lesions. Neuroradiol J. 2014;27:213–221Google Scholar

Henry, M, Amor, M, Henry, I, Ethevenot, G, Tzvetanov, K, Chati, Z. Percutaneous transluminal angioplasty of the subclavian arteries. J Endovasc Surg. 1999;6:33–41Google Scholar

Schillinger, M, Haumer, M, Schillinger, S, Ahmadi, R, Minar, E. Risk stratification for subclavian artery angioplasty: Is there an increased rate of restenosis after stent implantation? J Endovasc Ther. 2001;8:550–557Google Scholar

Chastain, HD 2nd, Campbell, MS, Iyer, S, Roubin, GS, Vitek, J, Mathur, A, et al. Extracranial vertebral artery stent placement: In-hospital and follow-up results. J Neurosurg. 1999;91:547–552Google Scholar

Piotin, M, Spelle, L, Martin, JB, Weill, A, Rancurel, G, Ross, IB, et al. Percutaneous transluminal angioplasty and stenting of the proximal vertebral artery for symptomatic stenosis. AJNR Am J Neuroradiol. 2000;21:727–731Google Scholar

Higashida, R, Tsai, F, Halbach, V, Dowd, C, Hieshima, G. Transluminal angioplasty, thrombolysis, and stenting for extracranial and intracranial cerebral vascular disease. Journal of Interventional Cardiology. 1996;9:245–255Google Scholar

SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): Study results. Stroke. 2004;35:1388–1392Google Scholar

Edgell, RC, Zaidat, OO, Gupta, R, Abou-Chebl, A, Linfante, I, Xavier, A, et al. Multicenter study of safety in stenting for symptomatic vertebral artery origin stenosis: Results from the Society of Vascular and Interventional Neurology Research Consortium. Journal of Neuroimaging. 2013;23:170–174Google Scholar

Meyers, PM, Schumacher, HC, Tanji, K, Higashida, RT, Caplan, LR. Use of stents to treat intracranial cerebrovascular disease. Annu Rev Med. 2007;58:107–122Google Scholar

Higashida, R, Meyers, PM, Connors, JJ 3rd, Sacks, D, Strother, CM, Barr, JD, et al. Intracranial angioplasty and stenting for cerebral atherosclerosis: A position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. J Vasc Interv Radiol. 2005;16:1281–1285Google Scholar

Gress, DR, Smith, WS, Dowd, CF, Van Halbach, V, Finley, RJ, Higashida, RT. Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery. 2002;51:23–27; discussion 27–29Google Scholar

Marks, MP, Marcellus, M, Norbash, AM, Steinberg, GK, Tong, D, Albers, GW. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke. 1999;30:1065–1069Google Scholar

Connors, JJ 3rd, Wojak, JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: Evolution of technique and short-term results. J Neurosurg. 1999;91:415–423Google Scholar

Takis, C, Kwan, ES, Pessin, MS, Jacobs, DH, Caplan, LR. Intracranial angioplasty: Experience and complications. AJNR Am J Neuroradiol. 1997;18:1661–1668Google Scholar

Gomez, CR, Misra, VK, Liu, MW, Wadlington, VR, Terry, JB, Tulyapronchote, R, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke. 2000;31:95–99Google Scholar

Yu, W, Smith, WS, Singh, V, Ko, NU, Cullen, SP, Dowd, CF, et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology. 2005;64:1055–1057Google Scholar

Kessler, IM, Mounayer, C, Piotin, M, Spelle, L, Vanzin, JR, Moret, J. The use of balloon-expandable stents in the management of intracranial arterial diseases: A 5-year single-center experience. AJNR Am J Neuroradiol. 2005;26:2342–2348Google Scholar

Marks, MP, Marcellus, ML, Do, HM, Schraedley-Desmond, PK, Steinberg, GK, Tong, DC, et al. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: Long-term follow-up. AJNR Am J Neuroradiol. 2005;26:525–530Google Scholar

Wojak, JC, Dunlap, DC, Hargrave, KR, DeAlvare, LA, Culbertson, HS, Connors, JJ 3rd. Intracranial angioplasty and stenting: Long-term results from a single center. AJNR Am J Neuroradiol. 2006;27:1882–1892Google Scholar

Henkes, H, Miloslavski, E, Lowens, S, Reinartz, J, Liebig, T, Kuhne, D. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology. 2005;47:222–228Google Scholar

Bose, A, Hartmann, M, Henkes, H, Liu, HM, Teng, MM, Szikora, I, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: The WingSpan study. Stroke. 2007;38:1531–1537CrossRefGoogle ScholarPubMed

Fiorella, D, Levy, EI, Turk, AS, Albuquerque, FC, Niemann, DB, Aagaard-Kienitz, B, et al. US multicenter experience with the WingSpan stent system for the treatment of intracranial atheromatous disease: Periprocedural results. Stroke. 2007;38:881–887Google Scholar

Chimowitz, MI, Lynn, MJ, Derdeyn, CP, Turan, TN, Fiorella, D, Lane, BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003Google Scholar

Derdeyn, CP, Chimowitz, MI, Lynn, MJ, Fiorella, D, Turan, TN, Janis, LS, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): The final results of a randomised trial. Lancet. 2014;383:333–341Google Scholar

Zaidat, O. VISSIT trial final results. Sixth Annual Meeting of the Society of Vascular and Interventional Neurology. October 26–27, Houston, TX, 2013Google Scholar

Liebeskind, DS, Cotsonis, GA, Saver, JL, Lynn, MJ, Turan, TN, Cloft, HJ, et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011;69:963–974Google Scholar

Montorsi, P, Galli, S, Ravagnani, PM, Trabattoni, D, Fabbiocchi, F, Lualdi, A, et al. Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: Preliminary report. J Endovasc Ther. 2012;19:734–742Google Scholar

Vajda, Z, Aguilar, M, Göhringer, T, Horváth-Rizea, D, Bäzner, H, Henkes, H. Treatment of intracranial atherosclerotic disease with a balloon-expandable paclitaxel eluting stent. Clin Neuroradiol. 2012;22:227–233Google Scholar

Gupta, R, Al-Ali, F, Thomas, AJ, Horowitz, MB, Barrow, T, Vora, NA, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37:2562–2566Google Scholar

Shuchman, M. Trading restenosis for thrombosis? New questions about drug-eluting stents. N Engl J Med. 2006;355:1949–1952Google Scholar

Collen, D. On the regulation and control of fibrinolysis. Edward Kowalski memorial lecture. Thromb Haemost. 1980;43:77–89Google Scholar

Sloan, MA. Thrombolysis and stroke. Past and future. Arch Neurol. 1987;44:748–768Google Scholar

del Zoppo, G, Hosomi, N. Mechanisms of thrombolysis. In Lyden, P, ed. Thrombolytic Therapy for Acute Stroke. Totowa, NJ: Humana Press; 2005:3–27Google Scholar

Meyer, JS, Gilroy, J, Barnhart, MI, Johnson, JF. Anticoagulants plus streptokinase therapy in progressive stroke. JAMA. 1964;189:373Google Scholar

Meyer, JS GJ, Barnhart, ME, Johnson, JF. Therapeutic thrombolysis in cerebral thromboembolism: Randomized evaluation of streptokinase. In Millikan, C, Whisnant, JP, eds. Cerebral Vascular Disease, Fourth Princeton Conference. New York, NY: Grune & Stratton; 1965:200–213Google Scholar

Del Zoppo, GJ. Thrombolytic therapy in cerebrovascular disease. Stroke. 1988;19:1174–1179Google Scholar

Pessin, MS, del Zoppo, GJ, Furlan, AJ. Thrombolytic treatment in acute stroke: Review and update of selected topics. In Moskowitz, MA, Caplan, LR, eds. Cerebrovascular Diseases, 19th Princeton Conference, 1994. Boston, MA: Butterworth–Heinemann; 1995:409–418Google Scholar

Caplan, LR. Caplan’s Stroke: A Clinical Approach. Boston, MA: Butterworth–Heinemann; 2000Google Scholar

Caplan, LR. Thrombolysis 2004: The good, the bad, and the ugly. Rev Neurol Dis. 2004;1:16–26Google Scholar

Grond, M, Rudolf, J, Schmulling, S, Stenzel, C, Neveling, M, Heiss, WD. Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke. Arch Neurol. 1998;55:466–469Google Scholar

Wardlaw, JM, Murray, V, Berge, E, Del Zoppo, GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2009:CD000213CrossRefGoogle Scholar

Sandercock, P, Wardlaw, JM, Lindley, RI, Dennis, M, Cohen, G, Murray, G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (The Third International Stroke Trial [IST-3]): A randomised controlled trial. Lancet. 2012;379:2352–2363Google Scholar

Hacke, W, Kaste, M, Fieschi, C, Toni, D, Lesaffre, E, von Kummer, R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017–1025Google Scholar

Fisher, M, Pessin, MS, Furian, AJ. ECASS: Lessons for future thrombolytic stroke trials. European Cooperative Acute Stroke Study. JAMA. 1995;274:1058–1059Google Scholar

Steiner, T, Bluhmki, E, Kaste, M, Toni, D, Trouillas, P, von Kummer, R, et al. The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS study group. European Cooperative Acute Stroke Study. Cerebrovasc Dis. 1998;8:198–203Google Scholar

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581–1587Google Scholar

Ingall, TJ, O’Fallon, WM, Asplund, K, Goldfrank, LR, Hertzberg, VS, Louis, TA, et al. Findings from the reanalysis of the NINDS tissue plasminogen activator for Acute Ischemic Stroke Treatment Trial. Stroke. 2004;35:2418–2424Google Scholar

Lansberg, MG, Schrooten, M, Bluhmki, E, Thijs, VN, Saver, JL. Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke. 2009;40:2079–2084Google Scholar

Lees, KR, Bluhmki, E, von Kummer, R, Brott, TG, Toni, D, Grotta, JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695–1703Google Scholar

Wardlaw, JM, Murray, V, Berge, E, del Zoppo, G, Sandercock, P, Lindley, RL, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: An updated systematic review and meta-analysis. Lancet. 2012;379:2364–2372Google Scholar

Lansberg, M, Bluhmki, E, Saver, J. Number needed to treat estimates for tPA per 90-minute time interval. Stroke. 2008;39:560Google Scholar

Hacke, W, Kaste, M, Fieschi, C, von Kummer, R, Davalos, A, Meier, D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245–1251Google Scholar

Clark, WM, Wissman, S, Albers, GW, Jhamandas, JH, Madden, KP, Hamilton, S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: A randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA. 1999;282:2019–2026Google Scholar

Hacke, W, Donnan, G, Fieschi, C, Kaste, M, von Kummer, R, Broderick, JP, et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-Pa stroke trials. Lancet. 2004;363:768–774Google Scholar

Flaherty, ML JE, Kothari, RU, Broderick, JP. Intravenous thrombolytic therapy for acute ischemic stroke: Results of large, randomized clinical trials. In Lyden, P, ed. Thrombolytic Therapy for Acute Stroke. Totowa, NJ: Humana Press; 2005:111–127Google Scholar

Donnan, GA, Davis, SM, Chambers, BR, Gates, PC, Hankey, GJ, McNeil, JJ, et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet. 1995;345:578–579Google Scholar

del Zoppo, GJ, Higashida, RT, Furlan, AJ, Pessin, MS, Rowley, HA, Gent, M. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism. Stroke. 1998;29:4–11Google Scholar

Furlan, A, Higashida, R, Wechsler, L, Gent, M, Rowley, H, Kase, C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA. 1999;282:2003–2011Google Scholar

Furlan, AJ, Katzan, I, Abou-Chebl, A, Russman, A. Intra-arterial thrombolysis in acute ischemic stroke. In Lyden, P, ed. Thrombolytic Therapy for Acute Stroke. Totowa, NJ: Humana Press; 2005:159–184Google Scholar

Ogawa, A, Mori, E, Minematsu, K, Taki, W, Takahashi, A, Nemoto, S, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke. 2007;38:2633–2639Google Scholar

Saver, JL. Intra-arterial fibrinolysis for acute ischemic stroke: The message of MELT. Stroke. 2007;38:2627–2628Google Scholar

Adams, HP Jr., Brott, TG, Furlan, AJ, Gomez, CR, Grotta, J, Helgason, CM, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1996;27:1711–1718Google Scholar

Practice advisory: Thrombolytic therapy for acute ischemic stroke – summary statement. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 1996;47:835–839Google Scholar

Jauch, EC, Saver, JL, Adams, HP Jr., Bruno, A, Connors, JJ, Demaerschalk, BM, et al. Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947Google Scholar

Adams, HP Jr., del Zoppo, G, Alberts, MJ, Bhatt, DL, Brass, L, Furlan, A, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655–1711Google Scholar

Horowitz, SH. Thrombolytic therapy in acute stroke: Neurologists, get off your hands! Arch Neurol. 1998;55:155–157Google Scholar

Burton, T. Doctors push for more scans in stroke cases. Wall Street Journal. 2009:D1Google Scholar

American College of Emergency Physicians. Use of intravenous tPA for the management of acute stroke in the emergency department. www.acep.org, 2002Google Scholar

Adams, HP Jr, Kenton, EJ 3rd, Scheiber, SC, Juul, D. Vascular neurology: A new neurologic subspecialty. Neurology. 2004;63:774–776Google Scholar

Josephson, SA, Engstrom, JW, Wachter, RM. Neurohospitalists: An emerging model for inpatient neurological care. Ann Neurol. 2008;63:135–140Google Scholar

Scott, PA, Xu, Z, Meurer, WJ, Frederiksen, SM, Haan, MN, Westfall, MW, et al. Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: Baseline survey results from the increasing stroke treatment through interactive behavioral change tactic (INSTINCT) trial hospitals. Stroke. 2010;41:2026–2032Google Scholar

Schwamm, LH, Pancioli, A, Acker, JE 3rd, Goldstein, LB, Zorowitz, RD, Shephard, TJ, et al. Recommendations for the establishment of stroke systems of care: Recommendations from the American Stroke Association’s task force on the development of stroke systems. Stroke. 2005;36:690–703Google Scholar

Demaerschalk, BM, Durocher, DL. How diagnosis-related group 559 will change the US medicare cost reimbursement ratio for stroke centers. Stroke. 2007;38:1309–1312Google Scholar

Wahlgren, N, Ahmed, N, Davalos, A, Ford, GA, Grond, M, Hacke, W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): An observational study. Lancet. 2007;369:275–282Google Scholar

Fonarow, GC, Smith, EE, Saver, JL, Reeves, MJ, Bhatt, DL, Grau-Sepulveda, MV, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: Patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123:750–758Google Scholar

Saver, JL, Fonarow, GC, Smith, EE, Reeves, MJ, Grau-Sepulveda, MV, Pan, W, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309:2480–2488Google Scholar

Nakagawara, J, Minematsu, K, Okada, Y, Tanahashi, N, Nagahiro, S, Mori, E, et al. Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: The Japan post-marketing alteplase registration study (J-MARS). Stroke. 2010;41:1984–1989Google Scholar

Chao, AC, Hsu, HY, Chung, CP, Liu, CH, Chen, CH, Teng, MM, et al. Outcomes of thrombolytic therapy for acute ischemic stroke in Chinese patients: The Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) study. Stroke. 2010;41:885–890Google Scholar

Schwamm, LH, Reeves, MJ, Pan, W, Smith, EE, Frankel, MR, Olson, D, et al. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation. 2010;121:1492–1501Google Scholar

Alberts, MJ, Latchaw, RE, Jagoda, A, Wechsler, LR, Crocco, T, George, MG, et al. Revised and updated recommendations for the establishment of primary stroke centers: A summary statement from the brain attack coalition. Stroke. 2011;42:2651–2665Google Scholar

LaMonte, MP, Bahouth, MN, Hu, P, Pathan, MY, Yarbrough, KL, Gunawardane, R, et al. Telemedicine for acute stroke: Triumphs and pitfalls. Stroke. 2003;34:725–728Google Scholar

Audebert, HJ, Kukla, C, Clarmann von Claranau, S, Kuhn, J, Vatankhah, B, Schenkel, J, et al. Telemedicine for safe and extended use of thrombolysis in stroke: The telemedic pilot project for integrative stroke care (TEMPIS) in Bavaria. Stroke. 2005;36:287–291Google Scholar

Audebert, HJ, Kukla, C, Vatankhah, B, Gotzler, B, Schenkel, J, Hofer, S, et al. Comparison of tissue plasminogen activator administration management between telestroke network hospitals and academic stroke centers: The telemedical pilot project for integrative stroke care in Bavaria/Germany. Stroke. 2006;37:1822–1827Google Scholar

Meyer, BC, Raman, R, Hemmen, T, Obler, R, Zivin, JA, Rao, R, et al. Efficacy of site-independent telemedicine in the stroke doc trial: A randomised, blinded, prospective study. Lancet Neurol. 2008;7:787–795Google Scholar

Silva, GS, Farrell, S, Shandra, E, Viswanathan, A, Schwamm, LH. The status of telestroke in the United States: A survey of currently active stroke telemedicine programs. Stroke. 2012;43:2078–2085Google Scholar

Alberts, MJ, Wechsler, LR, Jensen, ME, Latchaw, RE, Crocco, TJ, George, MG, et al. Formation and function of acute stroke-ready hospitals within a stroke system of care recommendations from the brain attack coalition. Stroke. 2013;44:3382–3393Google Scholar

Hachinski, V, Donnan, GA, Gorelick, PB, Hacke, W, Cramer, SC, Kaste, M, et al. Stroke: Working toward a prioritized world agenda. Int J Stroke. 2010;5:238–256Google Scholar

Moynihan, B, Davis, D, Pereira, A, Cloud, G, Markus, HS. Delivering regional thrombolysis via a hub-and-spoke model. J R Soc Med. 2010;103:363–369Google Scholar

Gladstone, DJ, Rodan, LH, Sahlas, DJ, Lee, L, Murray, BJ, Ween, JE, et al. A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke. 2009;40:3841–3844Google Scholar

Song, S, Saver, J. Growth of regional stroke systems of care in the United States in the first decade of the 21st century. Stroke. 2011;42:e340Google Scholar

Schwamm, LH, Smith, E, Saver, JL, Reeves, M, Messe, S, Bhatt, D, et al. Temporal trends in the use of IV tPA among all ischemic stroke patients presenting to GWTG-stroke hospitals (abstract). Stroke. 2011;42:e104Google Scholar

Addo, J, Bhalla, A, Crichton, S, Rudd, AG, McKevitt, C, Wolfe, CDA. Provision of acute stroke care and associated factors in a multiethnic population: Prospective study with the South London Stroke Register. BMJ 2011;342:d744Google Scholar

Grau, AJ, Eicke, M, Biegler, MK, Faldum, A, Bamberg, C, Haass, A, et al. Quality monitoring of acute stroke care in Rhineland–Palatinate, Germany, 2001–2006. Stroke. 2010;41:1495–1500Google Scholar

Gumbinger, C, Reuter, B, Stock, C, Sauer, T, Wietholter, H, Bruder, I, et al. Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: Retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials. BMJ. 2014;348:g3429Google Scholar

Marler, JR, Winters Jones, P, EMR, M. The National Institute of Neurological Disorders and Stroke: Proceedings of National Symposium on Rapid Identification and Treatment of Acute Stroke. Bethesda, MD: National Institute of Neurological Disorders and Stroke; 1997Google Scholar

Summers, D, Leonard, A, Wentworth, D, Saver, JL, Simpson, J, Spilker, JA, et al. Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: A scientific statement from the American Heart Association. Stroke. 2009;40:2911–2944Google Scholar

Xian, Y, Smith, EE, Zhao, X, Peterson, ED, Olson, DM, Hernandez, AF, et al. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke. Stroke. 2014;45:1387–1395Google Scholar

Ford, AL, Williams, JA, Spencer, M, McCammon, C, Khoury, N, Sampson, TR, et al. Reducing door-to-needle times using Toyota’s lean manufacturing principles and value stream analysis. Stroke. 2012;43:3395–3398Google Scholar

Fonarow, GC, Zhao, X, Smith, EE, Saver, JL, Reeves, MJ, Bhatt, DL, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA. 2014;311:1632–1640Google Scholar

Qureshi, AI, Suri, MF, Nasar, A, He, W, Kirmani, JF, Divani, AA, et al. Thrombolysis for ischemic stroke in the United States: Data from national hospital discharge survey 1999–2001. Neurosurgery. 2005;57:647–654Google Scholar

Albers, GW, Bates, VE, Clark, WM, Bell, R, Verro, P, Hamilton, SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) Study. JAMA. 2000;283:1145–1150Google Scholar

Demchuk, AM, Tanne, D, Hill, MD, Kasner, SE, Hanson, S, Grond, M, et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology. 2001;57:474–480Google Scholar

Katzan, IL, Furlan, AJ, Lloyd, LE, Frank, JI, Harper, DL, Hinchey, JA, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience. JAMA. 2000;283:1151–1158Google Scholar

Katzan, IL, Hammer, MD, Furlan, AJ, Hixson, ED, Nadzam, DM. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: A Cleveland update. Stroke. 2003;34:799–800Google Scholar

Weimar, C, Kraywinkel, K, Maschke, M, Diener, HC. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator. Cerebrovasc Dis. 2006;22:429–431Google Scholar

Heuschmann, PU, Berger, K, Misselwitz, B, Hermanek, P, Leffmann, C, Adelmann, M, et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: The German Stroke Registers Study Group. Stroke. 2003;34:1106–1113Google Scholar

Sobesky, J, Frackowiak, M, Zaro Weber, O, Hahn, M, Moller-Hartmann, W, Rudolf, J, et al. The Cologne stroke experience: Safety and outcome in 450 patients treated with intravenous thrombolysis. Cerebrovasc Dis. 2007;24:56–65Google Scholar

Toni, D, Lorenzano, S, Puca, E, Prencipe, M. The SITS-MOST Registry. Neurol Sci. 2006;27 Suppl 3:S260–262Google Scholar

Lisboa, RC, Jovanovic, BD, Alberts, MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke. 2002;33:2866–2871Google Scholar

Qureshi, AI, Ali, Z, Suri, MF, Kim, SH, Shatla, AA, Ringer, AJ, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery. 2001;49:41–48;discussion 48–50Google Scholar

Arnold, M, Schroth, G, Nedeltchev, K, Loher, T, Remonda, L, Stepper, F, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke. 2002;33:1828–1833Google Scholar

Edwards, MT, Murphy, MM, Geraghty, JJ, Wulf, JA, Konzen, JP. Intra-arterial cerebral thrombolysis for acute ischemic stroke in a community hospital. AJNR Am J Neuroradiol. 1999;20:1682–1687Google Scholar

Suarez, JI, Sunshine, JL, Tarr, R, Zaidat, O, Selman, WR, Kernich, C, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2094–2100Google Scholar

Molina, CA, Saver, JL. Extending reperfusion therapy for acute ischemic stroke: Emerging pharmacological, mechanical, and imaging strategies. Stroke. 2005;36:2311–2320Google Scholar

Rajajee, V, Saver, J. Prehospital care of the acute stroke patient. Tech Vasc Interv Radiol. 2005;8:74–80Google Scholar

Crocco, T, Gullett, T, Davis, SM, Flores, N, Sauerbeck, L, Jauch, E, et al. Feasibility of neuroprotective agent administration by prehospital personnel in an urban setting. Stroke. 2003;34:1918–1922Google Scholar

Saver, JL, Starkman, S, Eckstein, M, Stratton, SJ, Franklin, D, Pratt, TM, et al. for the FAST-MAG Investigators and Coordinators. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N Engl J Med 2015;372:528–536Google Scholar

Saver, JL. The 2012 Feinberg lecture: Treatment swift and treatment sure. Stroke. 2013;44:270–277Google Scholar

Ankolekar, S, Fuller, M, Cross, I, Renton, C, Cox, P, Sprigg, N, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: The Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial. Stroke. 2013;44:3120–3128Google Scholar

Hougaard, KD, Hjort, N, Zeidler, D, Sorensen, L, Norgaard, A, Hansen, TM, et al. Remote ischemic preconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: A randomized trial. Stroke. 2014;45:159–167Google Scholar

Walter, S, Kostopoulos, P, Haass, A, Keller, I, Lesmeister, M, Schlechtriemen, T, et al. Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: A randomised controlled trial. Lancet Neurol. 2012;11:397–404Google Scholar

Weber, JE, Ebinger, M, Rozanski, M, Waldschmidt, C, Wendt, M, Winter, B, et al. Prehospital thrombolysis in acute stroke: Results of the PHANTOM-S pilot study. Neurology. 2013;80:163–168Google Scholar

Ebinger, M, Winter, B, Wendt, M, Weber, JE, Waldschmidt, C, Rozanski, M, et al. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: A randomized clinical trial. JAMA. 2014;311:1622–1631Google Scholar

Rajan, S, Baraniuk, S, Parker, S, Wu, T-C, Bowry, R, Grotta, JC. Implementing a mobile stroke unit program in the United States. Why, how and how much? JAMA Neurology 2015;72(2):229–234Google Scholar

del Zoppo, GJ, Poeck, K, Pessin, MS, Wolpert, SM, Furlan, AJ, Ferbert, A, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78–86Google Scholar

Wolpert, SM, Bruckmann, H, Greenlee, R, Wechsler, L, Pessin, MS, del Zoppo, GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol. 1993;14:3–13Google Scholar

Montavont, A, Nighoghossian, N, Derex, L, Hermier, M, Honnorat, J, Philippeau, F, et al. Intravenous rt-PA in vertebrobasilar acute infarcts. Neurology. 2004;62:1854–1856Google Scholar

Lindsberg, PJ, Soinne, L, Tatlisumak, T, Roine, RO, Kallela, M, Happola, O, et al. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA. 2004;292:1862–1866Google Scholar

Kent, DM, Selker, HP, Ruthazer, R, Bluhmki, E, Hacke, W. Can multivariable risk–benefit profiling be used to select treatment-favorable patients for thrombolysis in stroke in the 3 -to 6-hour time window? Stroke. 2006;37:2963–2969Google Scholar

Davis, SM, Donnan, GA, Parsons, MW, Levi, C, Butcher, KS, Peeters, A, et al. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol. 2008;7:299–309Google Scholar

Fink, JN, Kumar, S, Horkan, C, Linfante, I, Selim, MH, Caplan, LR, et al. The stroke patient who woke up: Clinical and radiological features, including diffusion and perfusion MRI. Stroke. 2002;33:988–993Google Scholar

Manawadu, D, Bodla, S, Keep, J, Jarosz, J, Kalra, L. An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Stroke. 2013;44:427–431Google Scholar

Barber, PA, Zhang, J, Demchuk, AM, Hill, MD, Buchan, AM. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility. Neurology. 2001;56:1015–1020Google Scholar

Smith, EE, Abdullah, AR, Petkovska, I, Rosenthal, E, Koroshetz, WJ, Schwamm, LH. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke. 2005;36:2497–2499Google Scholar

Rajajee, V, Kidwell, C, Starkman, S, Ovbiagele, B, Alger, JR, Villablanca, P, et al. Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology. 2006;67:980–984Google Scholar

Urra, X, Ariño, H, Llull, L, Amaro, S, Obach, V, Cervera, Á, et al. The outcome of patients with mild stroke improves after treatment with systemic thrombolysis. PLoS One. 2013;8:e59420Google Scholar

Selim, M, Kumar, S, Fink, J, Schlaug, G, Caplan, LR, Linfante, I. Seizure at stroke onset: Should it be an absolute contraindication to thrombolysis? Cerebrovasc Dis. 2002;14:54–57Google Scholar

Saqqur, M, Uchino, K, Demchuk, AM, Molina, CA, Garami, Z, Calleja, S, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke. 2007;38:948–954Google Scholar

Schellinger, PD, Fiebach, JB, Jansen, O, Ringleb, PA, Mohr, A, Steiner, T, et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol. 2001;49:460–469Google Scholar

Koroshetz, WJ, Lev, MH. Contrast computed tomography scan in acute stroke: “You can’t always get what you want but … You get what you need”. Ann Neurol. 2002;51:415–416Google Scholar

Wintermark, M, Reichhart, M, Thiran, JP, Maeder, P, Chalaron, M, Schnyder, P, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol. 2002;51:417–432Google Scholar

Kidwell, CS, Alger, JR, Saver, JL. Beyond mismatch: Evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke. 2003;34:2729–2735Google Scholar

Sanak, D, Nosal, V, Horak, D, Bartkova, A, Zelenak, K, Herzig, R, et al. Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis. Neuroradiology. 2006;48:632–639Google Scholar

Kohrmann, M, Juttler, E, Fiebach, JB, Huttner, HB, Siebert, S, Schwark, C, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: A cohort study. Lancet Neurol. 2006;5:661–667Google Scholar

Davis, SM, Donnan, GA, Butcher, KS, Parsons, M. Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging. Curr Opin Neurol. 2005;18:47–52Google Scholar

Prosser, J, Butcher, K, Allport, L, Parsons, M, MacGregor, L, Desmond, P, et al. Clinical–diffusion mismatch predicts the putative penumbra with high specificity. Stroke. 2005;36:1700–1704Google Scholar

Butcher, KS, Parsons, M, MacGregor, L, Barber, PA, Chalk, J, Bladin, C, et al. Refining the perfusion–diffusion mismatch hypothesis. Stroke. 2005;36:1153–1159Google Scholar

Hacke, W, Albers, G, Al-Rawi, Y, Bogousslavsky, J, Davalos, A, Eliasziw, M, et al. The Desmoteplase In Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36:66–73Google Scholar

Hjort, N, Butcher, K, Davis, SM, Kidwell, CS, Koroshetz, WJ, Rother, J, et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke. 2005;36:388–397Google Scholar

Schellinger, PD, Thomalla, G, Fiehler, J, Kohrmann, M, Molina, CA, Neumann-Haefelin, T, et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: An analysis of 1210 patients. Stroke. 2007;38:2640–2645Google Scholar

Lansberg, MG, Thijs, VN, Bammer, R, Kemp, S, Wijman, CA, Marks, MP, et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke. 2007;38:2275–2278Google Scholar

Fiehler, J, Albers, GW, Boulanger, JM, Derex, L, Gass, A, Hjort, N, et al. Bleeding risk analysis in stroke imaging before thrombolysis (BRASIL): Pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke. 2007;38:2738–2744Google Scholar

Lee, SJ, Saver, JL, Liebeskind, DS, Ali, L, Ovbiagele, B, Kim, D, et al. Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts. Stroke. 2010;41:2587–2591Google Scholar

Lansberg, MG, Lee, J, Christensen, S, Straka, M, De Silva, DA, Mlynash, M, et al. Rapid automated patient selection for reperfusion therapy: A pooled analysis of the echoplanar imaging thrombolytic evaluation trial (EPITHET) and the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Stroke. 2011;42:1608–1614Google Scholar

Scalzo, F, Alger, JR, Hu, X, Saver, JL, Dani, KA, Muir, KW, et al. Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features. Magn Reson Imaging. 2013;31:961–969Google Scholar

Warach, S, Al-Rawi, Y, Furlan, AJ, Fiebach, JB, Wintermark, M, Lindstén, A, et al. Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: Insights from the desmoteplase in acute stroke trials. Stroke. 2012;43:2313–2318Google Scholar

Furlan, AJ, Eyding, D, Albers, GW, Al-Rawi, Y, Lees, KR, Rowley, HA, et al. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37:1227–1231Google Scholar

Hacke, W, Furlan, AJ, Al-Rawi, Y, Davalos, A, Fiebach, JB, Gruber, F, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): A prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2009;8:141–150Google Scholar

Liberatore, GT, Samson, A, Bladin, C, Schleuning, WD, Medcalf, RL. Vampire bat salivary plasminogen activator (desmoteplase): A unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke. 2003;34:537–543Google Scholar

Wintermark, M, Reichhart, M, Cuisenaire, O, Maeder, P, Thiran, JP, Schnyder, P, et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke. 2002;33:2025–2031Google Scholar

Obach, V, Oleaga, L, Urra, X, Macho, J, Amaro, S, Capurro, S, et al. Multimodal CT-assisted thrombolysis in patients with acute stroke: A cohort study. Stroke. 2011;42:1129–1131Google Scholar

Parsons, M, Spratt, N, Bivard, A, Campbell, B, Chung, K, Miteff, F, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366:1099–1107Google Scholar

Hu, HH, Teng, MM, Hsu, LC, Wong, WJ, Wang, LM, Luk, YO, et al. A pilot study of a new thrombolytic agent for acute ischemic stroke in Taiwan within a five-hour window. Stroke. 2006;37:918–919Google Scholar

Alexandrov, AV, Demchuk, AM, Burgin, WS, Robinson, DJ, Grotta, JC. Ultrasound-enhanced thrombolysis for acute ischemic stroke: Phase l. Findings of the CLOTBUST trial. J Neuroimaging. 2004;14:113–117Google Scholar

Barlinn, K, Barreto, AD, Sisson, A, Liebeskind, DS, Schafer, ME, Alleman, J, et al. Clotbust-hands free: Initial safety testing of a novel operator-independent ultrasound device in stroke-free volunteers. Stroke. 2013;44:1641–1646Google Scholar

Lewandowski, CA, Frankel, M, Tomsick, TA, Broderick, J, Frey, J, Clark, W, et al. Combined intravenous and intra-arterial r-tPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598–2605Google Scholar

Ernst, R, Pancioli, A, Tomsick, T, Kissela, B, Woo, D, Kanter, D, et al. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke. 2000;31:2552–2557Google Scholar

The IMS II Trial Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke. 2004;35:904–911Google Scholar

The IMS Study Investigators. Hemorrhage in the Interventional Management of Stroke Study. Stroke. 2006;37:847–851Google Scholar

Sekoranja, L, Loulidi, J, Yilmaz, H, Lovblad, K, Temperli, P, Comelli, M, et al. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: A transcranial color-coded duplex sonography – guided pilot study. Stroke. 2006;37:1805–1809Google Scholar

The IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke. 2007;38:2127–2135Google Scholar

Keris, V, Rudnicka, S, Vorona, V, Enina, G, Tilgale, B, Fricbergs, J. Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol. 2001;22:352–358Google Scholar

Butcher, K, Shuaib, A, Saver, J, Donnan, G, Davis, SM, Norrving, B, et al. Thrombolysis in the developing world: Is there a role for streptokinase? Int J Stroke. 2013;8:560–565Google Scholar

Ducrocq, X, Bracard, S, Taillandier, L, Anxionnat, R, Lacour, JC, Guillemin, F, et al. Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke. J Neuroradiol. 2005;32:26–32Google Scholar

Sugg, RM, Noser, EA, Shaltoni, HM, Gonzales, NR, Campbell, MS, Weir, R, et al. Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke. AJNR Am J Neuroradiol. 2006;27:769–773Google Scholar

Macleod, MR, Davis, SM, Mitchell, PJ, Gerraty, RP, Fitt, G, Hankey, GJ, et al. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis. 2005;20:12–17Google Scholar

Inoue, T, Kimura, K, Minematsu, K, Yamaguchi, T. A case-control analysis of intra-arterial urokinase thrombolysis in acute cardioembolic stroke. Cerebrovasc Dis. 2005;19:225–228Google Scholar

Tirschwell, DL, Coplin, WM, Becker, KJ, Vogelzang, P, Eskridge, J, Haynor, D, et al. Intra-arterial urokinase for acute ischemic stroke: Factors associated with complications. Neurology. 2001;57:1100–1103Google Scholar

Fanale, PL. Thrombolytic Therapy for Acute Ischemic Stroke in Acute Stroke, Bench to Bedside. New York, NY: Informa Healthcare; 2007Google Scholar

The Ancrod Stroke Study Investigators. Ancrod for the treatment of acute ischemic brain infarction. Stroke. 1994;25:1755–1759Google Scholar

Sherman, DG, Atkinson, RP, Chippendale, T, Levin, KA, Ng, K, Futrell, N, et al. Intravenous ancrod for treatment of acute ischemic stroke: The STAT study: A randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA. 2000;283:2395–2403Google Scholar

Hossmann, V, Heiss, WD, Bewermeyer, H, Wiedemann, G. Controlled trial of ancrod in ischemic stroke. Arch Neurol. 1983;40:803–808Google Scholar

Olinger, CP, Brott, TG, Barsan, WG, Hedges, JR, Glas-Greenwalt, P, Pollak, VE, et al. Use of ancrod in acute or progressing ischemic cerebral infarction. Ann Emerg Med. 1988;17:1208–1209Google Scholar

Hennerici, MG, Kay, R, Bogousslavsky, J, Lenzi, GL, Verstraete, M, Orgogozo, JM. Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: A randomised controlled trial. Lancet. 2006;368:1871–1878Google Scholar

Van De Werf, F, Adgey, J, Ardissino, D, Armstrong, PW, Aylward, P, Barbash, G, et al. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial. Lancet. 1999;354:716–722Google Scholar

Haley, EC, Thompson, JLP, Grotta, JC, Lyden, PD, Hemmen, TG, Brown, DL, et al. Phase IIB/III trial of tenecteplase in acute ischemic stroke: Results of a prematurely terminated randomized clinical trial. Stroke. 2010;41:707–711Google Scholar

Parsons, M, Spratt, N, Bivard, A, Campbell, B, Chung, K, Miteff, F, et al. A randomized trial of tenecteplase versus alteplace for acute ischemic stroke. N Engl J Med 2012;366:1099–1107Google Scholar

Leary, MC, Saver, JL, Gobin, YP, Jahan, R, Duckwiler, GR, Vinuela, F, et al. Beyond tissue plasminogen activator: Mechanical intervention in acute stroke. Ann Emerg Med. 2003;41:838–846Google Scholar

Saver, JL. Improving reperfusion therapy for acute ischaemic stroke. J Thromb Haemost. 2011;9 Suppl 1:333–343Google Scholar

Baltsavias, G, Yella, S, Al Shameri, RA, Luft, A, Valvanis, A. Intra-arterial administration of papaverine during mechanical thrombectomy for acute ischemic stroke. J Stroke Cerebrovasc Dis 2015;24:41–47Google Scholar

Rha, JH, Saver, JL. The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke. 2007;38:967–973Google Scholar

Levy, EI, Siddiqui, AH, Crumlish, A, Snyder, KV, Hauck, EF, Fiorella, DJ, et al. First food and drug administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (Stent-Assisted Recanalization in acute Ischemic Stroke). Stroke. 2009;40:3552–3556Google Scholar

Velat, GJ, Hoh, BL, Levy, EI, Mocco, J. Primary intracranial stenting in acute ischemic stroke. Curr Cardiol Rep. 2010;12:14–19Google Scholar

The Penumbra Pivotal Stroke Trial Investigators. The Penumbra Pivotal Stroke Trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40:2761–2768Google Scholar

Kulcsár, Z, Bonvin, C, Pereira, VM, Altrichter, S, Yilmaz, H, Lövblad, KO, et al. Penumbra system: A novel mechanical thrombectomy device for large-vessel occlusions in acute stroke. Am J Neuroradiol. 2010;31:628–633Google Scholar

Psychogios, M-N, Kreusch, A, Wasser, K, Mohr, A, Gröschel, K, Knauth, M. Recanalization of large intracranial vessels using the penumbra system: A single-center experience. Am J Neuroradiol. 2012;33:1488–1493Google Scholar

Jankowitz, B, Grandhi, R, Horev, A, Aghaebrahim, A, Jadhav, A, Linares, G, et al. Primary manual aspiration thrombectomy (MAT) for acute ischemic stroke: Safety, feasibility and outcomes in 112 consecutive patients. J NeuroIntervent Surg. 2014; doi:10.1136/neurintsurg-2013–011024Google Scholar

Turk, AS, Frei, D, Fiorella, D, Mocco, J, Baxter, B, Siddiqui, A, et al. Adapt FAST study: A direct aspiration first pass technique for acute stroke thrombectomy. J NeuroIntervent Surg. 2014;6:260–264Google Scholar

Smith, WS, Sung, G, Starkman, S, Saver, JL, Kidwell, CS, Gobin, YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke. 2005;36:1432–1438Google Scholar

Smith, WS, Sung, G, Saver, J, Budzik, R, Duckwiler, G, Liebeskind, DS, et al. Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke. 2008;39:1205–1212Google Scholar

Smith, WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the Multi Mechanical Embolus Removal In Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol. 2006;27:1177–1182Google Scholar

Jahan, R. Solitaire flow-restoration device for treatment of acute ischemic stroke: Safety and recanalization efficacy study in a swine vessel occlusion model. AJNR Am J Neuroradiol. 2010;31:1938–1943Google Scholar

Hausegger, K, Hauser, M, Kau, T. Mechanical thrombectomy with stent retrievers in acute ischemic stroke. Cardiovasc Intervent Radiol. 2014;37:863–874Google Scholar

Saver, JL, Jahan, R, Levy, EI, Jovin, TG, Baxter, B, Nogueira, RG, et al. Solitaire flow restoration device versus the MERCI retriever in patients with acute ischaemic stroke (SWIFT): A randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241–1249Google Scholar

Nogueira, RG, Lutsep, HL, Gupta, R, Jovin, TG, Albers, GW, Walker, GA, et al. TREVO versus MERCI retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): A randomised trial. Lancet. 2012;380:1231–1240Google Scholar

Ciccone, A, Valvassori, L. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368:2433–2434Google Scholar

Broderick, JP, Palesch, YY, Demchuk, AM, Yeatts, SD, Khatri, P, Hill, MD, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893–903Google Scholar

Kidwell, CS, Jahan, R, Gornbein, J, Alger, JR, Nenov, V, Ajani, Z, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914–923Google Scholar

Berkheimer, OA, Fransen, PSS, Beumer, D, van den Berg, LA, Lingsma, HF, Yoo, AJ, et al. for the Mr CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20Google Scholar

Goyal, M, Demchuk, AM, Menon, BK, Eesa, M, Rempel, JL, Thronton, J, et al. for the ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030Google Scholar

Saver, J, Goyal, M, Bonafe, A, Diener, H-C, Levy, EI, Pereira, VM, et al. for the SWIFT PRIME Investigators. SolitaireTM with the intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for randomized, controlled, multicenter study comparing the SolitaireTM revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. Int J Stroke. 2015;10:439–448Google Scholar

Campbell, BC. EXTEND-IA: Endovascular therapy after intravenous t-PA versus t-PA alone for ischemic stroke using CT perfusion imaging selection. International Stroke Conference, 2015: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_471810.pdfGoogle Scholar

Delgado-Mederos, R, Rovira, A, Alvarez-Sabin, J, Ribo, M, Munuera, J, Rubiera, M, et al. Speed of tPA-induced clot lysis predicts DWI lesion evolution in acute stroke. Stroke. 2007;38:955–960Google Scholar

Mazighi, M, Chaudhry, SA, Ribo, M, Khatri, P, Skoloudik, D, Mokin, M, et al. Impact of onset-to-reperfusion time on stroke mortality: A collaborative pooled analysis. Circulation. 2013;127:1980–1985Google Scholar

Wunderlich, MT, Goertler, M, Postert, T, Schmitt, E, Seidel, G, Gahn, G, et al. Recanalization after intravenous thrombolysis: Does a recanalization time window exist? Neurology. 2007;68:1364–1368Google Scholar

Uchino, K, Anderson, DC. Better late than never?: The story of arterial recanalization in acute ischemic stroke. Neurology. 2007;68:1335–1336Google Scholar

Sacco, RL, Chong, JY, Prabhakaran, S, Elkind, MS. Experimental treatments for acute ischaemic stroke. Lancet. 2007;369:331–341Google Scholar

Hemmen, TM, Raman, R, Guluma, KZ, Meyer, BC, Gomes, JA, Cruz-Flores, S, et al. Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTUS-l): Final results. Stroke. 2010;41:2265–2270Google Scholar

Lyden, PD, Hemmen, TM, Grotta, J, Rapp, K, Raman, R. Endovascular therapeutic hypothermia for acute ischemic stroke: ICTUS 2/3 protocol. Int J Stroke. 2014;9:117–125Google Scholar

Steiner, T, Hacke, W. Combination therapy with neuroprotectants and thrombolytics in acute ischaemic stroke. Eur Neurol. 1998;40:1–8Google Scholar

Alexandrov, AV, Grotta, JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002;59:862–867Google Scholar

Qureshi, AI, Saad, M, Zaidat, OO, Suarez, JI, Alexander, MJ, Fareed, M, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002;33:1916–1919Google Scholar

Abciximab Emergent Stroke Treatment Trial (ABESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: Results of a randomized phase 2 trial. Stroke. 2005;36:880–890Google Scholar

Mangiafico, S, Cellerini, M, Nencini, P, Gensini, G, Inzitari, D. Intravenous glycoprotein IIB/IIIA inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. AJNR Am J Neuroradiol. 2005;26:2595–2601Google Scholar

Straub, S, Junghans, U, Jovanovic, V, Wittsack, HJ, Seitz, RJ, Siebler, M. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Stroke. 2004;35:705–709Google Scholar